Gateway to South San Francisco


Gateway of Pacific is a new landmark, delivering premier laboratory and office space at the front door to South San Francisco’s flourishing biotechnology community. This fully-integrated ±2.2 million square foot campus is designed to the highest institutional standards, featuring distinct and robust buildings within an active, urban-park setting.


The next phases of the campus are currently under construction and will deliver ±440,000 rentable square feet of laboratory and office space in an 8/9-story tower ready for tenant improvements in early 2021 and ±360,000 rentable square feet of laboratory and office space in a 12-story tower ready for tenant improvements in late-2021.

Take a Virtual Tour

Representative Lab/Office Space

TRAVERSE (Amenities Building)

Featured News

BioMed Realty Welcomes Amgen to Its Gateway of Pacific Campus

Another S&P 500 Life Science Enterprise to Occupy BioMed Realty’s Landmark Campus

BioMed Realty (“BioMed”), a leading real estate owner and operator for the life science industry, announced today that Amgen will occupy BioMed’s Gateway of Pacific campus in South San Francisco under a new long-term lease for 240,000 sq. ft. Founded in 1980 and headquartered in California, Amgen is one of the world’s leading biotechnology companies committed to unlocking the potential of biology for patients suffering from serious illnesses. The new location will house Amgen’s Bay Area scientists and employees focused on cardiometabolic, inflammation and oncology research.

Read More

San Francisco Business Times

Biotech building boom continues as BioMed starts second phase of big South San Francisco complex

With the first phase of its massive Gateway of Pacific project leased and nearing completion, BioMed Realty will officially start on the more than 430,000-square-foot second part of the South San Francisco development.

Read More

End Point News

AbbVie hatches plans for a major new R&D hub close to its partners in Bay Area’s buzzy Oyster Point

AbbVie has signed on to be the first tenant of a massive new research center in Oyster Point, joining a flock of biopharma peers that’s set up shop in the increasingly popular South San Francisco neighborhood.

Read More